| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anticoagulation in splanchnic and cerebral vein thrombosis: An international vignette‐based survey
|
Riva, Nicoletta
|
|
|
4 |
7 |
p. 1192-1202
|
artikel
|
| 2 |
Anticoagulation in splanchnic and cerebral vein thrombosis: Still groping in the dark
|
Klok, Frederikus A.
|
|
|
4 |
7 |
p. 1080-1082
|
artikel
|
| 3 |
Camelid‐derived single‐chain antibodies in hemostasis: Mechanistic, diagnostic, and therapeutic applications
|
Peyron, Ivan
|
|
|
4 |
7 |
p. 1087-1100
|
artikel
|
| 4 |
Core and shell platelets of a thrombus: A new microfluidic assay to study mechanics and biochemistry
|
DeCortin, Michael E.
|
|
|
4 |
7 |
p. 1158-1166
|
artikel
|
| 5 |
COVID‐19 pandemic perspectives: A scientific silver lining?
|
Dobson, Dre'Von A.
|
|
|
4 |
7 |
p. 1083-1086
|
artikel
|
| 6 |
Detection of mosaics in hemophilia A by deep Ion Torrent sequencing and droplet digital PCR
|
Manderstedt, Eric
|
|
|
4 |
7 |
p. 1121-1130
|
artikel
|
| 7 |
Diversity, equity, and inclusion in publishing: Calling thrombosis and hemostasis journals to action in support of women
|
Pendlebury, Elizabeth C.
|
|
|
4 |
7 |
p. 1076-1079
|
artikel
|
| 8 |
Effects of thrombomodulin alfa on hemostatic parameters in disseminated intravascular coagulation: Post hoc analysis of a phase 3 randomized controlled trial
|
Ito, Takashi
|
|
|
4 |
7 |
p. 1141-1149
|
artikel
|
| 9 |
Epidemiology and 3‐year outcomes of combined oral contraceptive–associated distal deep vein thrombosis
|
Galanaud, Jean‐Philippe
|
|
|
4 |
7 |
p. 1216-1223
|
artikel
|
| 10 |
Extracellular tyrosyl‐tRNA synthetase cleaved by plasma proteinases and stored in platelet α‐granules: Potential role in monocyte activation
|
Won, Eric
|
|
|
4 |
7 |
p. 1167-1177
|
artikel
|
| 11 |
Issue Information
|
|
|
|
4 |
7 |
p. 1071-1075
|
artikel
|
| 12 |
Left ventricular thrombus and pulmonary embolism: A case series of thrombosis in COVID‐19 in Thai patients
|
Nanthatanti, Nithita
|
|
|
4 |
7 |
p. 1224-1229
|
artikel
|
| 13 |
Monitoring standard and extended half‐life products in hemophilia: Assay discrepancies for factor VIII and IX in pre‐ and postinfusion samples
|
Augustsson, Cecilia
|
|
|
4 |
7 |
p. 1114-1120
|
artikel
|
| 14 |
Nonacog beta pegol (N9‐GP) in hemophilia B: First report on safety and efficacy in previously untreated and minimally treated patients
|
Chan, Anthony K.
|
|
|
4 |
7 |
p. 1101-1113
|
artikel
|
| 15 |
Preventing venous thromboembolism in oncology practice: Use of risk assessment and anticoagulation prophylaxis
|
Martin, Karlyn A.
|
|
|
4 |
7 |
p. 1211-1215
|
artikel
|
| 16 |
Prostasin and hepatocyte growth factor B in factor VIIa generation: Serine protease knockdowns in zebrafish
|
Khandekar, Gauri
|
|
|
4 |
7 |
p. 1150-1157
|
artikel
|
| 17 |
Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis
|
Nopp, Stephan
|
|
|
4 |
7 |
p. 1178-1191
|
artikel
|
| 18 |
Second‐line treatments and outcomes for immune thrombocytopenia: A retrospective study with electronic health records
|
Lal, Lincy S.
|
|
|
4 |
7 |
p. 1131-1140
|
artikel
|
| 19 |
Type 2A von Willebrand disease and systemic sclerosis: Vonicog alfa reduced gastrointestinal bleeding
|
Korsten, Peter
|
|
|
4 |
7 |
p. 1230-1234
|
artikel
|
| 20 |
Venous thromboembolism in multiple myeloma is associated with increased mortality
|
Schoen, Martin W.
|
|
|
4 |
7 |
p. 1203-1210
|
artikel
|
Tijdschrift beschrijving